Back to STATE STREET CORP STATE STREET CORP

NVCTNVCT
Showing 8 of 11 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in NUVECTIS PHARMA INC

STATE STREET CORP holds 248,198 shares of NVCT (NUVECTIS PHARMA INC), worth $4.6M as of 2026-Q2. The position was increased (+49.0% shares). NVCT represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$4.6M

Current Shares

248,198

Total Value Change

+$4.5M

Total Shares Change

+232,898

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
248,198
+49.0%
$4.6M0.0%$18.39
37
2026-Q1
Increased
166,516
+7.7%
$1.3M0.0%$8.71
19
2025-Q4
Increased
154,666
+13.1%
$1.2M0.0%$7.38
19
2025-Q3
Increased
136,716
+20.4%
$823,0300.0%$5.92
20
2025-Q2
Increased
113,579
+309.3%
$848,4350.0%$7.55
27
2025-Q1
Increased
27,750
+26.1%
$271,1180.0%$10.46
20
2024-Q4
Increased
22,000
+43.8%
$119,0200.0%$5.14
20
2024-Q3
Unchanged
15,300
0.0%
$96,2370.0%$6.18
0

Other major holders of NVCT: BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used